Merck & Co. Inc. (NYSE: MRK) will be presenting results of the Keynote-042 trial ... this could be another pharma asset for the company that could drive …
The U.S. Food and Drug Administration issued an alert on issues discovered in …
Two American pharmaceutical giants reported earnings this morning, both showing flagging sales – but one ended the day with a gain. Merck & Co. Inc. (NYSE: MRK) shares gained 1.05% to close at $58.58 while Pfizer Inc. (NYSE: PFE) …
Merck & Co Inc. (MRK) announced Monday morning that its Phase 3 study of ... Merck gapped up at the open Monday and has continued to rise in early trade. The stock is now up 1.86 at $59.03 and has climbed to over a 2-month high.
Investors in Merck & Co., Inc. MRK need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 1, 2017 $65 Call had some of the highest implied volatility of all equity options today. What is …
Merck & Co. (NYSE: MRK) announced plans to reduce the size of its U.S. sales force by 1,200 positions. "Merck is taking this step as part of our previously disclosed, continuing efforts to optimize our cost base and improve Merck's …
State Of Alaska Department Of Revenue acquired 16,520 shares as Merck & Co Inc (MRK)s stock declined 2.46%. The …
In after-hours, the stock was up 25.20% to $176 ... MD closed Monday's trading at $45.91, down 2.13%. Merck & Co. Inc.'s (MRK) supplemental Biologics License Application for KEYTRUDA has been accepted for priority review by the …
The stock topped all stock searches on google today. Merck & Co., Inc. (NYSE: MRK) closed at 36.88, up by 0.67(1.85%) yesterday. Merck has been making significant R&D investments in increasing the level of good cholesterol, which are …
May 6, 2014 11:40 AM Moody's Sees the Sale of Merck's (MRK) Consumer Products Business as Credit-Positive Move Jan 13, 2014 02:38 PM Moody's Sees Merck's (MRK) Divestiture Plans as Credit-Negative Event May 14, 2013 05:37 …